Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/molecules25215052 http://scihub22266oqcxt.onion/10.3390/molecules25215052 33143272!7662698!33143272     free     free     free       Molecules 2020 ; 25 (21): ? Nephropedia Template TP {{tp|p=33143272|t=2020. Lysosomotropic Features and Autophagy Modulators among Medical Drugs: Evaluation of Their Role in Pathologies |pdf=|usr=}}{{33143272}} gab.com Text Lysosomotropic Features and Autophagy Modulators among Medical Drugs: Evaluation of Their Role in Pathologies JO: Molecules http://www.kidney.de/pget.php?&tw=1&pmid=33143272 #FOAvip The concept of lysosomotropic agents significantly changed numerous aspects of cellular biochemistry, biochemical pharmacology, and clinical medicine. In the present review, we focused on numerous low-molecular and high-molecular lipophilic basic compounds and on the role of lipophagy and autophagy in experimental and clinical medicine. Attention was primarily focused on the most promising agents acting as autophagy inducers, which offer a new window for treatment and/or prophylaxis of various diseases, including type 2 diabetes mellitus, Parkinson's disease, and atherosclerosis. The present review summarizes current knowledge on the lysosomotropic features of medical drugs, as well as autophagy inducers, and their role in pathological processes. Twit Text FOAVip Lysosomotropic Features and Autophagy Modulators among Medical Drugs: Evaluation of Their Role in Pathologies ????Molecules http://www.kidney.de/pget.php?&tw=1&pmid=33143272 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33143272 #FOAvip English Wikipedia <ref>{{Cite pmid|33143272}}</ref> Lysosomotropic Features and Autophagy Modulators among Medical Drugs: Evaluation of Their Role in Pathologies #MMPMID33143272 Korolenko TA; Johnston TP; Vetvicka V Molecules 2020[Oct]; 25 (21): ? PMID33143272show ga The concept of lysosomotropic agents significantly changed numerous aspects of cellular biochemistry, biochemical pharmacology, and clinical medicine. In the present review, we focused on numerous low-molecular and high-molecular lipophilic basic compounds and on the role of lipophagy and autophagy in experimental and clinical medicine. Attention was primarily focused on the most promising agents acting as autophagy inducers, which offer a new window for treatment and/or prophylaxis of various diseases, including type 2 diabetes mellitus, Parkinson's disease, and atherosclerosis. The present review summarizes current knowledge on the lysosomotropic features of medical drugs, as well as autophagy inducers, and their role in pathological processes. |*Pharmaceutical Preparations[MESH] |Animals[MESH] |Atherosclerosis/*drug therapy/metabolism/pathology[MESH] |Autophagy/*drug effects[MESH] |Diabetes Mellitus, Type 2/*drug therapy/metabolism/pathology[MESH] |Humans[MESH]Lysosomotropic Features and Autophagy Modulators among Medical Drugs: (epmc).pdf DeepDyve Pubget Overpricing